The expanding demand for specific immunological research and therapeutic creation has spurred significant improvements in recombinant growth factor generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently produced using various expression platforms, including microbial hosts, higher cell cultures, and viral